Detalhe da pesquisa
1.
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma.
Cancer Sci
; 114(4): 1606-1615, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478334
2.
Pudexacianinium (ASP5354) chloride for ureter visualization in participants undergoing laparoscopic, minimally invasive colorectal surgery.
Surg Endosc
; 37(9): 7336-7347, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474823
3.
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
J Neurooncol
; 155(3): 297-306, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34689306
4.
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Cancer
; 126(12): 2821-2828, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154928
5.
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
J Neurooncol
; 148(3): 599-606, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506369
6.
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
Oncology (Williston Park)
; 32(2): e11-e19, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492949
7.
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
Oncology (Williston Park)
; 32(1): 17-22, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29447417
8.
Risk factors for the development of paclitaxel-induced neuropathy in breast cancer patients.
J Peripher Nerv Syst
; 23(2): 129-133, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29696771
9.
Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
Br J Haematol
; 177(1): 72-79, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28211579
10.
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
J Neurooncol
; 131(3): 507-516, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204914
11.
Phase II study of MEDI-575, an anti-platelet-derived growth factor-α antibody, in patients with recurrent glioblastoma.
J Neurooncol
; 131(1): 185-191, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27844311
12.
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
J Neurooncol
; 133(3): 589-594, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28510787
13.
Newer Strategies for the Management of Low-Grade Gliomas.
Oncology (Williston Park)
; 31(9): 680-2, 684-5, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29071695
14.
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas.
J Neurooncol
; 129(1): 139-46, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27300524
15.
Central Nervous System Cancers, Version 1.2015.
J Natl Compr Canc Netw
; 13(10): 1191-202, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483059
16.
Low-grade glioma.
Cancer Treat Res
; 163: 75-87, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25468226
17.
Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.
Curr Treat Options Oncol
; 16(8): 38, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143268
18.
LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma.
Br J Haematol
; 165(5): 640-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24571259
19.
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.
J Natl Compr Canc Netw
; 12(11): 1517-23, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361798
20.
Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity.
J Neurooncol
; 118(1): 147-53, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574050